P099: Serum proteomic analysis reveals novel biomarkers associated with disease activity in pediatric patients with Crohn’s diseaseECCO'22Year: 2022
Authors: Werner, L.(1);Weiss, B.(2);Matar, M.(1);Shamir, R.(1);Shouval, D.(1);
(1)Schneider Children's Medical Center of Israel, Institute of Gastroenterology- Nutrition and Liver Diseases, Petah Tiqwa, Israel;(2)Edmond and Lliy Safra Children's Hospital, Pediatric Gastroenterology Unit, Ramat Gan, Israel;
P100: Serum inflammatory protein profiling to corroborate selection of therapy naïve moderate-to-severe pediatric Crohn’s disease patients eligible for first-line infliximab treatmentECCO'22Year: 2022
Authors: Jongsma , M.M.E.(1);Costes , L.M.M.(2);Tindemans , I.(2);Cozijnsen , M.A.(1);Raatgreep , R.H.C.(2);van Pieterson , M.(1);Li , Y.(3);Escher , J.C.(1);de Ridder , L.(1);Samsom , J.N.(2);
(1)Erasmus University Medical Center/Sophia Children's Hospital, Department of Pediatric Gastroenterology, Rotterdam, The Netherlands;(2)Erasmus University Medical Center, Laboratory of Paediatrics- Division of Gastroenterology and Nutrition, Rotterdam, The Netherlands;(3)Erasmus University Medical Center- Erasmus MC Cancer Institute, Department of Pathology & Clinical Bioinformatics, Rotterdam, The Netherlands;
P102: Changes in serum immune protein profiles following vedolizumab therapy in Inflammatory Bowel Disease.ECCO'22Year: 2022
Authors: O'Connell, J.(1,2);O'Connell, F.(2);O'Sullivan, J.(2);Kevans, D.(1,2,3);
(1)St James's Hospital, Gastroenterology, Dublin, Ireland;(2)Dublin University- Trinity College, Trinity Translational Medicine Institute, Dublin, Ireland;(3)Dublin University- Trinity College, School of Medicine, Dublin, Ireland;
P103: Identifying CES-1 positive myeloid cells with mass cytometry as a potential therapeutic target for Crohn’s diseaseECCO'22Year: 2022
Authors: HagemanMD, I.(1);Elfiky, A.(2);Becker, M.(2);Joustra, V.(1);Buskens, C.(3);Li Yim, A.(2);Hakvoort, T.(2);Verhoeff, J.(4);Garcia Vallejo, J.(4);D'Haens, G.(1);Wildenberg, M.(2);De Jonge, W.(2);
(1)Academic Medical Center AMC University of Amsterdam, Department of Gastroenterology & Hepatology, Amsterdam, The Netherlands;(2)Academic Medical Center AMC University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam, The Netherlands;(3)Academic Medical Center AMC University of Amsterdam, Department of Surgery, Amsterdam, The Netherlands;(4)Academic Medical Center AMC University of Amsterdam, Department of Molecular Cell Biology & Immunology- Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam, The Netherlands;
P104: Icariin Attenuates Intestinal Inflammation through Inhibition of the Nuclear Factor-ĸB signalingECCO'22Year: 2022
Authors: Soh, H.(1);Park, S.(2);Lee, H.J.(1);Koh, S.J.(1);Im, J.P.(1);Kim, J.S.(1);
(1)Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul, Korea- Republic Of;(2)Incheon Sejong Hospital, Department of Internal Medicine, Incheon, Korea- Republic Of;
P105: Treatment of the lower gastrointestinal tract Klebsiella infections by recombinant bacteriocin KvarIaECCO'22Year: 2022
Authors: Karaliute, I.(1);Ramonaite, R.(1);Kupcinskas, J.(2);Misiunas, A.(3);Denkovskiene, E.(3);Gleba, Y.(4);Razanskiene, A.(3);Skieceviciene, J.(1);
(1)Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania;(2)Lithuanian University of Health Sciences, Department of Gastroenterology, Kaunas, Lithuania;(3)UAB Nomads, Nomad Bioscience Gmbh, Vilnius, Lithuania;(4)NOMAD Bioscience GmbH, NOMAD Bioscience GmbH, Halle, Germany;
P106: Macrophages as a source of NOTCH Ligands in Crohn's disease: implications in fibrosisECCO'22Year: 2022
Authors: Edo, M.M.(1);Macias-Ceja, D.C.(2);Bauset, C.(2);Lis, L.(2);Coll, S.(2);Seco-Cervera, M.(3);Cosin-Roger, J.(3);Calatayud, S.(2);Barrachina, M.D.(2);Ortiz-Masiá, D.(1);
(1)Universitat de Valencia, Medicine, Valencia, Spain;(2)Universitat de Valencia, Farmacologia, Valencia, Spain;(3)FISABIO, Farmacologia, Valencia, Spain;
P107: IL10 secretion endows intestinal human iNKT cells with regulatory functions towards pathogenic T lymphocytes in Crohn's disease patientsECCO'22Year: 2022
Authors: Burrello, C.(1);Strati, F.(1);Diaz-Basabe, A.(1);Lattanzi, G.(1);Lopez, G.(2);Trombetta, E.(3);Conforti, F.S.(4);Botti, F.(5);Vecchi, M.(4);Fantini, M.C.(6);Caprioli, F.(4);Facciotti, F.(1);
(1)European Institute of Oncology, Experimental Oncology, Milano, Italy;(2)IRCCS Ospedale Policlinico Ca' Granda, Pathology Unit, Milan, Italy;(3)IRCCS Ospedale Policlinico Ca' Granda, Flow Cytometry Service, Milan, Italy;(4)IRCCS Ospedale Policlinico Ca' Granda, Gastroenterology and Endoscopy Unit, Milan, Italy;(5)IRCCS Ospedale Policlinico Ca' Granda, Surgery Unit, Milan, Italy;(6)University of Cagliari, Medical Science and Public Health- Gastroenterology Unit, Cagliari, Italy;
P109: Risk of cervical cancer in incident Ulcerative Colitis during the first 10 years after diagnosis: A nationwide population-based studyECCO'22Year: 2022
Authors: Kim, J.(1);Kim, H.(2);Park, S.C.(2);Lee, J.K.(3);Kang, D.R.(3);Kim, S.Y.(2);Kim, H.S.(2);Kim, H.M.(2);
(1)Yonsei University Wonju College of Medicine, Department of Medicine, Wonju, Korea- Republic Of;(2)Yonsei University Wonju College of Medicine, Department of Internal Medicine- Division of Gastroenterology and Hepatology, Wonju, Korea- Republic Of;(3)Yonsei University Wonju College of Medicine, Center of Biomedical Data Science, Wonju, Korea- Republic Of;
P110: Risk Factors of Clinical Relapses in Pediatric Luminal Crohn’s Disease, a Retrospective Cohort StudyECCO'22Year: 2022
Authors: Sassine, S.(1,2);Djani, L.(1,2);Cambron-Asselin, C.(1,2);Savoie-Robichaud, M.(1,2);Lin, Y.F.(1,2);Qaddouri, M.(1,2);Fadela-Zekhnine, S.(1,2);Grzywacz, K.(1,2,3);Groleau, V.(1,2,3);Dirks, M.(1,3);Drouin, É.(1,2,3);Halac, U.(1,3);Marchand, V.(1,3);Girard, C.(1,2,3);Courbette, O.(1,2,3);Patey, N.(1,2,4);Dal Soglio, D.(1,2,4);Deslandres, C.(1,2,3);Jantchou, P.(1,2,3);
(1)Université de Montréal, Faculty of Medicine, Montréal, Canada;(2)CHU Sainte-Justine, Research Center, Montréal, Canada;(3)CHU Sainte-Justine, Gastroenterology, Montréal, Canada;(4)CHU Sainte-Justine, Pathology, Montréal, Canada;
P111: Gut barrier markers in Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Nguyen, A.(1);Sparrow, M.P.(2);Moore, G.(3);Gibson, P.R.(2);
(1)Monash University- Alfred Health and Monash Health, Gastroenterology, Melbourne, Australia;(2)Monash University and Alfred Health, Gastroenterology, Melbourne, Australia;(3)Monash University and Monash Health, Gastroenterology, Melbourne, Australia;
P112: The road to disease control: Combination of histologic and endoscopic remission predicts long-term disease outcome in ulcerative colitisECCO'22Year: 2022
Authors: Bretschneider, F.(1);Kormilez, D.(2);Sari, S.(1);Pflaum, T.(3);Le, H.D.(1);Nikolaus, S.(4);Lassen, A.(4);Rosenstiel, P.(1);Roecken, C.(3);Szymczak, S.(2);Schreiber, S.(4);Aden, K.(4);
(1)Christian-Albrechts-University and University Hospital Schleswig-Holstein, Institute of Clinical Molecular Biology-, Kiel, Germany;(2)University of Luebeck University Hospital Schleswig-Holstein, Institute for Medical Biometry and Statistics, Luebeck, Germany;(3)University Medical Center Schleswig-Holstein Kiel, Institute of Pathology, Kiel, Germany;(4)University Medical Center Schleswig-Holstein Kiel, Department of Medicine I, Kiel, Germany;
P113: Defining the Safety of Early Ileostomy Closure After IPAAECCO'22Year: 2022
Authors: Clancy, C.(1);Connelly, T.(1);Jia, X.(1);Lipman, J.(1);Lightner, A.(1);Hull, T.(1);Steele, S.(1);HolubarMD- MS, S.(1);
(1)Cleveland Clinic, Department of Colon & Rectal Surgery, Cleveland, United States;
P114: SARS-CoV-2 infection in IBD: pandemic waves and predictors of severe or persistent COVID-19ECCO'22Year: 2022
Authors: Taxonera Samso, C.(1);Olivares, D.(1);Blanco , I.(2);Velasco, E.(2);Molina, S.(2);López , G.(2);López-García, O.N.(2);Alba, C.(1);Rey, E.(2);
(1)Hospital Clínico San Carlos, IBD Unit- Department of Gastroenterology, Madrid, Spain;(2)Hospital Clínico San Carlos, Gastroenterology, Madrid, Spain;
P115: Implementation of a vaccination tool in the electronic patient health record significantly increases vaccination coverageECCO'22Year: 2022
Authors: Fierens, L.(1);De Dycker, E.(2);Joly, J.(3);Vanhoutvin, T.(4);Verschueren, P.(3,5);De Haes, P.(4,6);Sabino, J.(1,2);Vermeire, S.(1,2);Ferrante, M.(1,2);
(1)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(2)UZ Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(3)UZ Leuven, Department of Rheumatology, Leuven, Belgium;(4)UZ Leuven, Department of Dermatology, Leuven, Belgium;(5)KU Leuven, Department of Development and Regeneration, Leuven, Belgium;(6)KU Leuven, Department of Microbiology- Immunology and Transplantation, Leuven, Belgium;
P116: Screening for low BMI and unintentional weight loss alone is insufficient to identify patients at risk for malnutrition in an outpatient IBD populationECCO'22Year: 2022
Authors: Hendrix, E.M.B.(1,2);Spooren, C.E.G.M.(1,2);Grommen, D.(2);Mujagic, Z.(1,2);Pierik, M.J.(1,2);Jonkers, D.M.A.E.(1,2);
(1)Maastricht University, School for Nutrition and Translational Research in Metabolism NUTRIM, Maastricht, The Netherlands;(2)Maastricht University Medical Centre+, Department of Internal Medicine- Division of Gastroenterology and Hepatology, Maastricht, The Netherlands;
